StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

6-(Dimethylamino)-2-fluoro-3-formylbenzonitrile → 6-Dimethylamino-2-fluoro-3-{[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamino]-methyl}-benzonitrile

HRID 1518029
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 1518029
[CH3:1][N:2]([CH3:14])[C:3]1[C:8]([C:9]#[N:10])=[C:7]([F:11])[C:6]([CH:12]=O)=[CH:5][CH:4]=1.[CH3:15][O:16][C:17]1[N:18]=[C:19]2[C:24](=[CH:25][CH:26]=1)[N:23]=[CH:22][CH:21]=[C:20]2[N:27]1[CH:35]=[C:34]2[C:29]([CH2:30][CH2:31][CH:32]([NH2:36])[CH2:33]2)=[N:28]1.[BH4-].[Na+]>CO.O>[CH3:1][N:2]([CH3:14])[C:3]1[C:8]([C:9]#[N:10])=[C:7]([F:11])[C:6]([CH2:12][NH:36][CH:32]2[CH2:31][CH2:30][C:29]3[C:34](=[CH:35][N:27]([C:20]4[C:19]5[C:24](=[CH:25][CH:26]=[C:17]([O:16][CH3:15])[N:18]=5)[N:23]=[CH:22][CH:21]=4)[N:28]=3)[CH2:33]2)=[CH:5][CH:4]=1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

6

Edukt 3

HCID 27367286-(Dimethylamino)-2-fluoro-3-formylbenzonitrileHCID 4311764Sodium borohydrideHCID 595606482-(6-Methoxy-[1,5]naphthyridin-4-yl)4,5,6,7-tetrahydro-2H-indazol-5-ylamine

Produkt 1

HCID 119483626-Dimethylamino-2-fluoro-3-{[2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamino]-methyl}-benzonitrileAusbeute 44 %

Reagenzien, Katalysatoren, Lösungsmittel 2

HCID 962WaterKatalysatorHCID 887MethanolLösungsmittel

Versuchsvorschrift

To a solution of 6-dimethylamino-2-fluoro-3-formyl-benzonitrile (69 mg, 0.36 mmol) in CH3OH (7 mL) was added 2-(6-methoxy-[1,5]naphthyridin-4-yl)-4,5,6,7-tetrahydro-2H-indazol-5-ylamine (11 mg, 0.34 mmol). The reaction mixture was stirred overnight at RT. NaBH4 (19 mg, 0.50 mmol) was then added and the suspension was stirred for 30 min at RT. The reaction mixture was diluted with a few drops of H2O, and the solvents were removed under reduced pressure. The crude material was purified by basic reverse phase to provide 70 mg (44%) of the title compound. MS (ESI): exact mass calculated for C26H26FN7O, 471.22; m/z found, 472.5 [M+H]+. 1H NMR (500 MHz, CDCl3): 9.09 (s, 1H), 8.75 (d, J=5.1, 1H), 8.26 (d, J=9.1, 1H), 8.14 (d, J=5.1, 1H), 7.38 (t, J=8.7, 1H), 7.18 (d, J=9.1, 1H), 6.58 (d, J=8.7, 1H), 4.75 (br s, 1H), 4.10 (s, 3H), 3.86 (s, 2H), 3.08 (s, 6H), 3.02-2.97 (m, 3H), 2.84-2.77 (m, 1H), 2.52 (dd, J=16.6, 9.9, 1H), 2.15-2.11 (m, 1H).

Aufarbeitung

  1. stirringthe suspension was stirred for 30 min at RT
  2. customthe solvents were removed under reduced pressure
  3. customThe crude material was purified by basic reverse phase

Quellen und Nachweise

ORD-Eintrag
ord-d23990084a7a4ea6bf25bb85014b8764
Quelldatensatz
uspto-grants-2012_07
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08232391B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion